A detailed history of Capitol Family Office, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Capitol Family Office, Inc. holds 1,160 shares of AMGN stock, worth $333,929. This represents 0.47% of its overall portfolio holdings.

Number of Shares
1,160
Previous 1,160 -0.0%
Holding current value
$333,929
Previous $362,000 3.04%
% of portfolio
0.47%
Previous 0.48%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $230,700 - $264,016
1,160 New
1,160 $261,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capitol Family Office, Inc. Portfolio

Follow Capitol Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitol Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capitol Family Office, Inc. with notifications on news.